ArticleBlood cancer journal2025

VEN in combination with 10-day DEC in newly diagnosed elderly or relapsed/refractory acute myeloid leukemia, and high-risk myelodysplastic syndrome: long term follow-up of a phase 2 trial.

Mahesh Swaminathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.